Skip to Content

4214 2.5 (Onglyza saxagliptin 2.5 mg)

Generic Name: saxagliptin

Pill with imprint 4214 2.5 is Yellow, Round and has been identified as Onglyza saxagliptin 2.5 mg. It is supplied by Bristol-Myers Squibb.

Onglyza is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Onglyza saxagliptin 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 4214 2.5

Onglyza saxagliptin 2.5 mg 4214 2.5
Onglyza saxagliptin 2.5 mg 4214 2.5
Onglyza saxagliptin 2.5 mg 4214 2.5 Front
Onglyza saxagliptin 2.5 mg 4214 2.5 Back
Onglyza saxagliptin 2.5 mg 4214 2.5
Onglyza saxagliptin 2.5 mg 4214 2.5

Onglyza

Generic Name
saxagliptin
Imprint
4214 2.5
Strength
saxagliptin 2.5 mg
Color
Yellow
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Dipeptidyl peptidase 4 inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bristol-Myers Squibb
Inactive Ingredients
lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00003-4214
00310-6100 AstraZeneca

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.